Study: Statin warnings may have been premature

PROVIDENCE – A systematic review of 25 clinical trials led by Rhode Island Hospital’s Dr. Brian Ott found that warnings regarding high cholesterol drugs’ effect on memory and cognitive function may have been premature. The drugs, known as statins, have been in a kind of limbo since a 2012 FDA finding linking them to cognitive…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -

No posts to display